AACE releases statement on continuous glucose monitoring among diabetics
JACKSONVILLE, Fla. The American Association of Clinical Endocrinologists said it believes that technology used for continuous glucose monitoring likely will become a key component of comprehensive diabetes management, particularly with Type 1 diabetes patients.
AACE issued a consensus statement that will be published in its official medical journal, Endocrine Practice, and identified which patients would be most appropriate for CGM; and also recommended that longer-term studies are needed to assess the outcomes beyond six to 12 months, noting that continued work to refine the accuracy and comfort of the devices is necessary.
“Over the past few years, a number of randomized, controlled clinical trials have been undertaken to evaluate the impact of real-time CGM devices in the treatment of Type 1 diabetes,” said Irl Hirsch, member of the American Association of Clinical Endocrinologists and co-chair of the CGM task force. “Several important observations have emerged. The most important is that the devices have to be used on a nearly daily basis to be effective in achieving and maintaining target A1C levels.”
CGM equipment, which can be purchased from a healthcare professional or facility, may be owned and operated by the patient and in real time see their blood-glucose levels, AACE said. Consequently, the patient may then adjust medication, nutrition and physical activity to improve glucose management, which includes the reduction of hypoglycemia.
“Continuous glucose monitoring is a relatively new, powerful tool to assist healthcare professionals in the management of diabetes mellitus,” said Victor Roberts, member of the American Association of Clinical Endocrinologists and co-chair of the CGM task force. “These devices actively engage our patients as partners in crafting the most optimal treatment plan and provide a rich source of data to individualize medical interventions that are most appropriate for each person with diabetes.”
NACDS Foundation supports new NEHI report on care teams, medication adherence
ALEXANDRIA, Va. A report by the New England Healthcare Institute that addressed the role of care teams in improving medication adherence among patients has received support from the charitable arm of the National Association of Chain Drug Stores.
The NACDS Foundation on Wednesday announced its support of the report "Medication Adherence and Care Teams: A Call for Demonstration Projects," which underscored the role of care teams — specifically, a “virtual care team,” a collaboration between small physician practices, community pharmacists and other external health professionals — in improving public health.
“Existing medical evidence supports the idea that team-based care can provide superior treatment of chronic conditions. Care teams are integral to the patient-centered medical home, and to other models of improved patient care that are designed to improve efficiency, affordability and, ultimately, patient outcomes,” the report noted.
NACDS Foundation president Edith Rosato applauded NEHI’s report, which is part of the "Thinking Outside the Pillbox" series of reports that examine medication adherence.
“When medications are not taken correctly, public health suffers,” Rosato said. “This report continues land-breaking work by NEHI in raising awareness of this critical health challenge, and identifying potential solutions.”
Safeway pharmacies offering pertussis booster vaccine
PLEASANTON, Calif. — Safeway pharmacies in California are responding to the state’s whooping cough (pertussis) emergency and now are offering Adacel, a booster vaccine for people ages 11 through 64 years, the grocer announced Wednesday.
The Adacel vaccine is available at all Safeway, Vons and Pavilions pharmacies on a walk-in basis, the company stated.
California’s incidences of whooping cough have reached a 60-year high, with more than 5,200 confirmed, suspected and possible cases this year, according to the California Department of Public Health. Because of the sudden increase, Gov. Arnold Schwarzenegger recently signed a bill requiring 7th-grade through 12th-grade students to get a whooping cough booster shot before the start of the next school year.
Agrowing number of insurance plans cover the whooping cough booster vaccine, decreasing or eliminating out-of-pocket costs, as well as eliminating the cost of a doctor’s office visit.